American Marconi Wireless News

NYSE - LSE

RBGPF	0%	75.17	$
CMSC	-2.2%	20.02	$
NGG	-0.85%	83.55	$
BTI	0.81%	60.58	$
GSK	-0.59%	51.24	$
RIO	-2.16%	84.56	$
BCE	0.61%	21.621	$
VOD	-1.78%	15.415	$
JRI	-1.02%	11.81	$
RYCEF	2.23%	17.9	$
AZN	-1.8%	186.05	$
CMSD	-1.76%	20.125	$
BP	-1.48%	43.94	$
RELX	-0.82%	39.695	$
BCC	-3.87%	69.865	$

Featured

David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid

Comedian and author David Walliams has been identified as the anonymous celebrity accused of sexual misconduct following a failed legal attempt to prevent media organizations from publishing his name. The High Court ruled against Walliams, who had argued that publication would lead to suicide, allowing The Guardian and ITN to reveal his identity alongside allegations spanning decades.

Fast Finance Pay Corp Reports Third Quarter 2026 Financial Results and Provides a Business Update

NEW YORK, NY / ACCESS Newswire / November 10, 2026 / Fast Finance Pay Corp. (OTCID:FFPP) ("Fast Finance" or the "Company"), developer of the privacy-focused communications ecosystem OK.secure, today reported financial results for the three and nine months ended September 30, 2026, and provided a business update.

Last news

'Part of Bogota's soul': how Colombia fired up the car-free movement

Fifty years ago, a 28-year-old Colombian with a bushy beard, flares and vintage Raleigh bicycle led a revolution on the streets of Bogota.

Nerds or crooks? 3D gun makers in spotlight after US executive murder

Gun rights activist Rob Pincus was worried when he heard a 3D-printed "ghost gun" was found on the alleged shooter in last week's notorious murder of a US health executive in New York.

Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations

Company to Maintain SIX Swiss Exchange Listing, U.S. ADR Program, and U.S. OTCQB Quotation

Willie's Grill & Icehouse Partners With Special Olympics Texas to Raise $12k for Sports Programming

SPECIAL OLYMPICS ATHLETES WORKED FOR TIPS AT ALL 20 STATEWIDE RESTAURANTS DURING IMMERSIVE FUNDRAISER

Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health's Crofelemer

Crofelemer is the subject of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - for the rare disease indications of microvillus inclusion disease (MVID) and/or short bowel syndrome with intestinal failure (SBS-IF) in the US, EU, and/or Middle East/North Africa regions; availability of IIT proof-of-concept results potentially in Q2 2025Virtual event 11:00 AM to 12:00 PM EasternRegistration open now for financial and business community; Click here to registerMassimo Radaelli, PhD, CEO of the rare disease-focused Jaguar family company Napo Therapeutics and President of Jaguar International, named ‘Best CEO BioPharmaceuticals of the Year'

New to The Street Show 616 Premieres Saturday on Bloomberg Television at 6:30 PM EST, Featuring HPB High Performance Battery AG With CEO Sebastian Heinz

Also featured are Banzai,PillSafe and The Sustainable Green Team

IAVI and IPD Sign Agreement Formalizing Collaboration to Advance Vaccine Development, Manufacturing, and Access in Africa

Agreement signed to establish collaboration between IAVI and IPDNew partnership aims to accelerate vaccine development and manufacturing for priority pathogens that disproportionately impact AfricaAligns with Africa’s regional vaccine manufacturing agenda and global priorities for pandemic preparedness

FlexCare Clinicians Donate Portable Video Game Stations to Dell Children's Medical Center

The Gaming Kiosks Provide Pediatric Patients With the Opportunity to Experience the Joy of Play During Their Hospital Stay

1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to provide an update to its news release dated November 29, 2024 (the "Announcement") announcing its request for a management cease trade order (the "MCTO") relating to the late filing of the Company's audited financial statements, management discussion & analysis and applicable CEO and CFO certifications for the year ended July 31, 2024 (the "Audited Filings").

LQR House Inc. Announces Change of Ticker Symbol From "LQR" to "YHC" Effective December 16, 2024

LQR House Inc. (the "Company" or "LQR House") (NASDAQ:LQR), a niche e-commerce platform specializing in the spirits and beverage industry, today announced that its shares of common stock will begin trading under the new ticker symbol "YHC" on the Nasdaq Capital Market prior to the market open on December 16, 2024. This change marks a strategic evolution for the Company, replacing the current ticker symbol "LQR" used since the Company's initial public offering in 2023.

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") and low-dose interferon therapeutics, today announced its participation in the Webull Corporate Connect Service (CCS). This initiative aims to further expand the Company's investor outreach and enhance transparency with its growing shareholder base.

Angle PLC Announces HER2 Presentation at SABCS

WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUMIndependent findings support ANGLE's HER2 assay development programmePotential for stratification of breast cancer patients for treatment with HER2 antibody drug conjugates

Syria's rebel victors expose ousted government's drug trade

The dramatic collapse of Bashar al-Assad's Syrian regime has thrown light into the dark corners of his rule, including the industrial-scale export of the banned drug captagon.

Prison will not silence me, Iran's Mohammadi says

Narges Mohammadi, the Iranian 2023 Nobel Peace Prize laureate on temporary medical leave from prison, said in a video call released Thursday that she would never let prison silence her.

UN investigators say 4,000 Syrian rights abusers identified

UN investigators say they have compiled secret lists of 4,000 perpetrators of serious crimes in Syria and hope the fall of Bashar al-Assad will help ensure accountability up to the highest level.

Syria govt pledges 'rule of law' after Assad's overthrow

Syria's interim government vowed on Thursday to institute the "rule of law" after years of abuses under ousted president Bashar al-Assad, as G7 powers pushed for an inclusive transition.

Fourth suspect held in deadly Dutch building collapse

Dutch police said Thursday that they had arrested a fourth suspect in connection with the deadly explosion that flattened an apartment block in The Hague, killing at least six people.

Sweden ends rape investigation allegedly targeting Kylian Mbappe

An investigation into alleged rape and sexual assault in Stockholm which Swedish media said targeted Real Madrid forward Kylian Mbappe has been closed due to insufficient evidence, the Swedish prosecutor said Thursday.

Sweden ends rape inquiry allegedly targeting Kylian Mbappe

Vulnerable Afghans struggle as Taliban rebuild Kabul roads

Mohammed Naeem knew the Kabul street where he and his brothers built matching apartment buildings was too narrow, but he was still in disbelief as their homes were reduced to rubble to widen the road.

Pope to champion popular Catholic traditions in Corsica

Pope Francis travels to the French island of Corsica Sunday to visit the small Catholic community, just days after having skipped the reopening ceremony for Notre Dame cathedral.

New Hope Network Unveils CPG and Retail Predictions for 2025

25 trends across food and beverage, beauty and personal care, wellness and supplements, consumer behavior and investment and business operations.

‘Confessions Of A CEO,’ Featuring RFK Jr., Hits Theaters In January

Deepak Chopra, Blue Zones' Dan Buettner, Tom Gegax Sound Populist Alarm

Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds

Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today announced it has entered into agreements with certain holders of its existing warrants for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 823,544 shares of common stock of the Company originally issued in August 2023, in November 2023, in April 2024, in July 2024 and September 2024, all at a reduced exercise price of $7.50 per share. The shares of common stock issuable upon exercise of the outstanding warrants are registered pursuant to effective registration statements on Form S-1 (File No. 333-273067), on Form S-3 (File No. 333-275710), on Form S-1 (File No. 333-278103), on Form S-1 (File No. 333-280226) and on Form S-1 (File No. 333-281892). The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $6.2 million, before deducting financial advisory fees.

Sojo Industries Partners with Blue Chip Beverage to Modernize Beverage Manufacturing

Collaboration Introduces Innovative, Modular, and Sustainable Production Solutions

Splash Beverage Group Expands Pulpoloco Sangria Distribution With Total Wine & More

Splash Beverage Group, Inc. (NYSE American:SBEV), an innovator in the beverage industry, proudly announces another 2024 retail expansion win. Total Wine & More, America's Wine Superstore and the country's largest independent retailer of fine wine, has authorized Pulpoloco Sangria across multiple states. This authorization includes Pulpoloco' Smooth Red and Crisp White Sangria varietals and spans over 115 stores in Arizona, California, Colorado, Florida, Illinois, Nevada, Texas, and Virginia.

100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial

Two of three patients achieved both complete remission and MRD-negative statusHigh response rates observed in earlier studies continue in ongoing mipletamig trialCohort 2 enrollment commencing

Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)

Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for prophylaxis of CTDThe majority of patients in the OnTarget placebo group on abemaciclib and pertuzumab-based therapies required dose reduction or elimination

Dr. Amir Bajoghli Presents on Advancements in Dermal Fillers and Facial Danger Zones at Georgetown/MedStar Washington Hospital

Dr. Amir Bajoghli recently had the honor of presenting a comprehensive educational session at Georgetown/MedStar Washington Hospital. The presentation focused on the latest advancements in dermal fillers and identifying facial danger zones, emphasizing safe practices and innovative approaches in aesthetic medicine. This session was part of an ongoing effort to educate Georgetown University medical students and dermatology residents, sharing best practices and cutting-edge techniques.

Cellev8 Nutrition Launches the First GLP1 Support Gummy With Clinically Tested Ingredients

CELLEV8 Launches First Post-GLP-1 Gummy Supplement: "SlimCell™" with Clinically Proven Ingredients to Compliment GLP-1

BlueFire Equipment Corp (BLFR) Demonstrates Progress Reporting 855.6% Growth in Q3 After Executing Its Restructuring Strategy

BlueFire Equipment Corp. (OTC Pink:BLFR) ("BLFR" or the "Company"), a specialist in emerging industry acquisitions, announces financial and operational progress on its restructuring and growth plans. As announced on July 11, 2024, BLFR acquired West Texas Dirt Movers, Inc. ("WTDM"), and Reed Exploration, LLC. As a result of the acquisitions, hiring experienced personnel into key leadership positions, and aggressively pursuing income-producing opportunities, the Company saw notable growth from second quarter to third quarter, 2024.

Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price

Transaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and growth potential.

American Marconi Wireless News - Boulevard (English)